Dallas, TX (PRWEB) August 31, 2013
The Trends in Therapeutic Partnering report provides the most comprehensive and in-depth insight into the 35 most popular therapeutic targets for partnering in the period 2007 to mid 2013.
The report provides a detailed understanding and analysis of the most popular therapeutic targets for partnering in the period 2007 to mid 2013. The majority of deals are discovery, preclinical and clinical stage whereby the licensee obtains a right or an option right to license or access the licensors compounds or product candidates. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.
One of the key aspects of partnering is finding those companies that are potential candidates for the development and commercialization of the next generation of therapeutic targets. A lot of resources are spent on finding partners, identifying their interests and making contact to initiate discussions.
Purchase a report copy at http://www.reportsnreports.com/Purchase.aspx?name=267194.
Using this report, dealmakers will effectively and efficiently target their partnering activities to deliver the company’s business development objectives. Over 300 charts allow quick understanding of therapeutic partnering trends since 2007, together with insight into which companies are active in each of the thirty five leading therapeutic areas.
Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered – contract documents provide this insight where press releases and databases do not.
The initial chapters of this report provide an orientation of therapeutic dealmaking.
Chapter 1 provides an introduction to the report, whilst chapter 2 provides an overview of therapeutic dealmaking since 2007, listing the top therapeutic areas for partnering by deal frequency and deal dollars committed by partnering companies.
Chapter 3 reviews the top pharma and biotech therapeutic partnering deals of 2007-2013 according to reported deal size.
Chapter 4 provides a summary of best practice on how to submit an opportunity to the leading therapeutic partnering companies, to ensure the building of relationships and to obtain a prompt assessment and response from the business development function of the prospective partner.
Chapter 5 lists forthcoming partnering events where valuable face to face meetings with big biotech provide a highly effective means of obtaining an interest in novel opportunities. These events are where dealmaking gets initiated through numerous back to back meetings.
The main body of the report is provided in chapter 6. In-depth profiles of each of the top 35 therapeutic target areas according to deal frequency during the period 2007-2013 provide everything required to assess the potential of the therapeutic area and its active partner companies. Each profile includes a partnering activity overview, deal financials (including headline, upfront and royalties rates, where available).
Each therapeutic profile provides a listing of partnering deals for the top fifteen most active companies in each therapeutic area, and is accompanied by an appendix that provides a comprehensive listing of deal records available at Current Agreements, each of which links directly to an online copy of the actual deal record plus contract document if filed with the SEC.
One of the key aspects of partnering is conducting due diligence on a partner to determine under what terms a prospective partner agrees to a partnering relationship.
Understanding the flexibility of a prospective partners’ negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered – contract documents provide this insight where press releases and databases do not.
This data driven report contains over 5,000 links to online copies of actual deal records at Current Agreements and contract documents, were submitted to the Securities Exchange Commission by companies and their partners. Contract documents provide the answers to numerous questions about a prospective partner’s flexibility on a wide range of important issues, many of which will have a significant impact on each party’s ability to derive value from the deal.
In summary, the report provides the reader with the tools necessary to understand trends in therapeutic partnering, the most active therapeutic areas in terms of deal frequency and leading deal maker companies, and the deal terms and structures achieved in such therapeutic partnering deals.
Complete report available at http://www.reportsnreports.com/reports/267194-trends-in-therapeutic-partnering.html.
Browse more reports on Pharmaceuticals Market at http://www.reportsnreports.com/market-research/pharmaceuticals/.
ReportsnReports.com is an online market research reports library of 350,000+ in-depth studies of over 5000 micro markets. We provide 24/7 online and offline support service to our customers.
Read the full story at http://www.prweb.com/releases/therapeutic-partnering/market-and-analysis/prweb11078514.htm.
Copyright©2012 Vocus, Inc.
All rights reserved